3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

News:

Welcome to 3StocksOnFire! US stock trading community (2005-2010) with 451+ documented trades and 15,000+ members. View Portfolios | Stock Articles | Quotes

Main Menu
Menu

Show posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.

Show posts Menu

Messages - armani425

#1
I've never posted a message on here before but i frequently read your post daily (VERY INFORMATIVE).  I am not sure if you read this post on Yahoo MB but from what this guy on yahoo posted, it looks like Generex repliled to his email.  take a look....

GNBT reply to my email
by: footman262000  03/25/06 04:44 pm
Msg: 156632 of 156853

Imediate below my email to GNBT
==============================================
My Email

Some simply answers to this questions, could give clarification ... & ... be help to investors.

1) The 40 million dollars, GNBT has now.
2) The Pre-IND meet with the FDA, for the Avian Flu vaccine. State,.... progress or none, as well as ... explain how close they are to submitting a IND application to the FDA?
3) Pre-NDS with Health Canada for Oral-lyn, How close are they to submitting a NDS application?
4) The Ecuador juvenile patients studies ... Provide updated info on these. How are they going?
5) How close are they, if not already ... Selling Oral-lyn in Ecuador.

Best of luck to board and employees

M


========= GNBT Response====================
GNBT reply

Generex Biotechnology Corporation management is aware of the article by
Lawrence Carrel posted on the SmartMoney.com website after market close on
March 24, 2006. While the article contains a number of categorical
falsehoods and misinterpretations, it is not feasible for Generex management
to make a fulsome public effort to correct all misinformation appearing in
the press and on internet blogs. However, outside legal counsel for Generex
has been instructed to take appropriate action in respect of the
SmartMoney.com article and it is Generex's intention to file a complaint
about the article with the United States Securities and Exchange Commission